Bioxel Pharma
2050 boul. René-Lévesque ouest
Bureau 104
Sainte-Foy
Québec
G1V 2K8
Canada
Tel: 418-654-9666
Fax: 418-654-9655
Website: http://www.bioxelpharma.com/
45 articles about Bioxel Pharma
-
Bioxel Pharma Seeks to Reprice Warrants Issued in November 2007
9/10/2008
-
Bioxel Pharma: 2008 Second Quarter Results
8/29/2008
-
Bioxel Pharma Grants Options to its New President and Chief Executive Officer
8/12/2008
-
Bioxel Pharma: 2008 First Quarter Results
5/30/2008
-
Bioxel Pharma Obtains $1 M in Financing
5/15/2008
-
Bioxel Pharma: First International Agreements for Docetaxel
5/13/2008
-
Bioxel Pharma Announces Departure of CEO
4/30/2008
-
Bioxel Pharma Announces Changes to its Management Team
4/30/2008
-
Bioxel Pharma: Grant of Options and Deferred Stock Units
4/11/2008
-
Bioxel Pharma: Fiscal 2007 Results
4/10/2008
-
Bioxel Pharma Release: Two International Reports on Patentability Confirm the Strenght of Bioxel's Docetaxel Patent Applications
4/2/2008
-
Bioxel Pharma/Moratorium on Repayment of Interest and Capital Under Certain Loans; Extension of a Loan Guarantee; and Issuance of 1,030,165 Warrants in Consideration Thereof
1/18/2008
-
Bioxel Pharma Third-Quarter 2007 Results
11/29/2007
-
Bioxel Pharma Builds Momentum in Europe With Significant Paclitaxel Order from Leading Generic Company
10/11/2007
-
Bioxel Pharma Wins Largest Paclitaxel Order from a Leading International Pharmaceutical Company
9/21/2007
-
Bioxel Pharma Second-Quarter 2007 Results
8/20/2007
-
Bioxel Pharma Registers its Docetaxel Drug in Canada
7/31/2007
-
Bioxel Pharma Lands Leading Asian Customer: Issue of 413,242 Common Shares in Payment of Interests on Certain of its Outstanding Convertible Debentures
7/17/2007
-
Bioxel Pharma Registers Docetaxel with the FDA
6/21/2007
-
Bioxel Pharma: First Quarter 2007 Results
5/30/2007